Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes (Q44114862)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2002
edit
Language Label Description Also known as
English
Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes
scientific article published in September 2002

    Statements

    Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes (English)
    Marco M Meyer
    Klaus Levin
    Thomas Grimmsmann
    Nina Perwitz
    Alexandra Eirich
    Henning Beck-Nielsen
    Harald H Klein
    1 September 2002
    2691-2697

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit